US NIH National Institute of Allergy and Infectious Diseases: Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)

The National Institute of Allergy and Infectious Diseases invites applications for its research to advance hepatitis B virus cure – HIV/HBV co-infection and HBV mono-infection (R01 clinical trial not allowed) funding opportunity. This supports innovative basic, translational and clinical research to identify and address the challenges to achieving HBV cure in the presence or absence of HIV.

About R01 Research Project Grants.

Funding & Duration

Application budgets are not limited but need to reflect the actual needs of the project. The maximum grant period is five years


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.

Comments are closed.